Zova uses AI-powered nutrient scanning to stop GLP-1 muscle loss. Track leucine, automate your protein, and protect your metabolism.
No credit card. No commitment. Early access only.

Zova's evidence-based architecture combines protein optimization, leucine tracking, and adaptive training to dramatically reduce muscle loss from an average of 39% down to just 8.7%.

Your at-a-glance hub for everything that matters. See exactly where you stand on protein, track your consistency streak, and monitor your muscle risk in real time — all tuned to your GLP-1 schedule.

Point your camera at any meal and get an instant breakdown of protein, leucine, and calories. Our AI is trained specifically on GLP-1 users' dietary patterns — it knows what injection day nausea looks like on a plate.

Injection days are different. Zova automatically adjusts your protein targets and meal suggestions based on your injection schedule, so you never fall short on the days that matter most.

Resistance training is the most powerful signal to preserve muscle on GLP-1. Zova builds progressive overload programs calibrated to your energy levels, recovery, and medication cycle.

Every meal, every scan, every day — your full nutritional history at a glance. Track trends, spot protein gaps, and see exactly how your eating patterns correlate with your muscle protection score.
"I lost 34 lbs in 4 months on semaglutide. My DEXA scan showed I kept 94% of my muscle mass. My doctor couldn't believe it."
"After my first round of Ozempic I lost 22 lbs but felt weak and my metabolism crashed. With Zova on my second round I feel stronger than before I started."
"The injection day meal planning alone was worth it. I used to skip protein completely on Wednesdays. Now I hit my targets even when I'm nauseous."
Zova is launching soon. Join the waitlist to get early access and founding member pricing.
Join the waitlist to be first in line when Zova launches. Founding members get lifetime access to the Full Protocol at Standard pricing.
No spam. No credit card. Just early access.